Medicare Enrolled
Dr. Jairus Ibabao, MD
Hematology & Oncology · Jamestown, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ibabao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibabao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ibabao
Dr. Jairus Ibabao is a hematology & oncology specialist in Jamestown, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ibabao performed 67,457 Medicare services across 1,957 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ibabao received a total of $3,238 from 16 pharmaceutical and/or device companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ibabao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 10% volume in NY
$3,238 industry payments
Medicare Practice Summary
Medicare Utilization ↗67,457
Medicare services
Top 10% in NY for hematology & oncology
1,957
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,212 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
30,900 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
19,380 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,033 | $6 | $31 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,588 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $43 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,442 | $8 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,161 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
953 | $10 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
578 | $93 | $241 |
| Anti-nausea injection (Aloxi/palonosetron) | 570 | $1 | $21 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
463 | $22 | $97 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
390 | $10 | $65 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
362 | $47 | $216 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
352 | $16 | $66 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
320 | $59 | $172 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
305 | $97 | $438 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
209 | $7 | $47 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
190 | $1 | $3 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
184 | $4 | $17 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
92 | $11 | $62 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
86 | $6 | $25 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $48 | $208 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
80 | $18 | $78 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $121 | $317 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
54 | $21 | $101 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
25 | $64 | $185 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $131 | $338 |
| Manual red blood cell count A laboratory test that manually counts the number of red blood cells in a blood sample. |
21 | $4 | $19 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.0% high complexity
61.6% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,238
Total received (2018-2024)
Avg $648/year across 5 years
Top 41% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
33
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,350 (72.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$852 (26.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$182
2023
$117
2022
$83
2021
$506
2018
$2,350
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$49
Merck Sharp & Dohme LLC
$39
PFIZER INC.
$25
TerSera Therapeutics LLC
$25
Amgen Inc.
$15
GlaxoSmithKline, LLC.
$14
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 62.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,350
E.R. Squibb & Sons, L.L.C.
$169
Janssen Biotech, Inc.
$137
GENZYME CORPORATION
$100
TG THERAPEUTICS, INC.
$98
Novartis Pharmaceuticals Corporation
$77
Merck Sharp & Dohme LLC
$54
Daiichi Sankyo Inc.
$51
TerSera Therapeutics LLC
$50
ARRAY BIOPHARMA INC
$30
Amgen Inc.
$29
GlaxoSmithKline, LLC.
$28
PFIZER INC.
$25
Genentech USA, Inc.
$15
Merck Sharp & Dohme Corporation
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 82.0% of all-time payments
Associated products mentioned in payments ›
BOSULIF · BRAFTOVI · CALQUENCE · DARZALEX · ERLEADA · EVENITY · Enhertu · KEYTRUDA · Nplate · OCREVUS · OJJAARA · OPDIVO · PIQRAY · PLUVICTO · REBLOZYL · UKONIQ · XALKORI · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
2
Per 100K population
1.6
County median income
$56,507
Nearest hospital
UPMC CHAUTAUQUA AT WCA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ibabao is a mixed practice specialist, with above-average Medicare volume (top 10% in NY), with consulting-driven industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ibabao experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Ibabao performed 30,900 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ibabao receive payments from pharmaceutical companies?
Yes. Dr. Ibabao received a total of $3,238 from 16 companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ibabao's costs compare to other hematology & oncology specialists in Jamestown?
Dr. Ibabao's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ibabao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jamestown
Browse hematology & oncology specialists in Jamestown ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology